Event Calendar
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Horizon Europe Cluster 4 brokerage
Getting ready for the opening of the calls for 2022 also implies finding (potential) partners. To facilitate this, you can participate in a brokerage event with pre-arranged online face-to-face meetings.
Detailed information and registration is on the brokerage website. The agenda is as simple and effective as possible: two full days (from 08:00 until 18:00) with available timeslots for bilateral meetings. The Brokerage Event registration will remain open for the upcoming three months, in order to support long-term networking opportunities. Want to read up on how such a brokerage works? Check this page.
This brokerage event complements the official and EC-organised Cluster 4 Info Day.
This event is open to representatives of companies, universities and research institutes interested in sharing new project ideas and finding collaboration partners.
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Event calendar
35 upcoming events view event calendarTestimonial
BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
